123 related articles for article (PubMed ID: 3181323)
1. Evaluation of live attenuated measles vaccines prepared in human diploid cells for reimmunization.
Mirchamsy H; Shafyi A; Nazari P; Ashtiani MP; Sassani A
Epidemiol Infect; 1988 Oct; 101(2):437-43. PubMed ID: 3181323
[TBL] [Abstract][Full Text] [Related]
2. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy evaluation of measles vaccine in fields].
Liu M
Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):292-4. PubMed ID: 1782660
[TBL] [Abstract][Full Text] [Related]
4. Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine.
Cerini CP; Arguedas J; Hernandez G; Frickey P; Douglas AV
Appl Microbiol; 1974 Apr; 27(4):763-6. PubMed ID: 4856949
[TBL] [Abstract][Full Text] [Related]
5. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
Just M; Berger R; Glück R; Wegmann A
Dev Biol Stand; 1986; 65():25-7. PubMed ID: 3549399
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
[TBL] [Abstract][Full Text] [Related]
8. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
[No Abstract] [Full Text] [Related]
9. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
[No Abstract] [Full Text] [Related]
10. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of the TD97 measles virus vaccine.
Suzuki K; Morita M; Katoh M; Kidokoro M; Saika S; Yoshizawa S; Hashizume S; Horiuchi K; Okabe N; Shinozaki T
J Med Virol; 1990 Nov; 32(3):194-201. PubMed ID: 2280260
[TBL] [Abstract][Full Text] [Related]
12. Measles in Tanzania: antibody response in children after vaccination and antibody state of mothers and newborns.
de Haas PW; Masurel N; Anker WJ
Trans R Soc Trop Med Hyg; 1983; 77(2):267-70. PubMed ID: 6868109
[TBL] [Abstract][Full Text] [Related]
13. Further-attenuated measles vaccine: characteristics and use.
Krugman S
Rev Infect Dis; 1983; 5(3):477-81. PubMed ID: 6879002
[TBL] [Abstract][Full Text] [Related]
14. A comparative field trial of five measles vaccines produced in human diploid cell, MRC-5.
Mirchamsy H; Shafyi A; Bahrami S; Kamali M; Nazari P; Razavi F; Ahourai P; Fatemi S; Amin-Salehi M
J Biol Stand; 1977; 5(1):1-18. PubMed ID: 838748
[No Abstract] [Full Text] [Related]
15. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.
Sabin AB; Flores Arechiga A; Fernández de Castro J; Sever JL; Madden DL; Shekarchi I; Albrecht P
JAMA; 1983 May; 249(19):2651-62. PubMed ID: 6341638
[TBL] [Abstract][Full Text] [Related]
16. [Clinical reactions and antibody responses of measles-susceptible healthy children to the live measles "AIK-C" vaccine(chick embryo tissue culture type)].
Okayama T
Kansenshogaku Zasshi; 1975 Apr; 49(4):150-8. PubMed ID: 811729
[No Abstract] [Full Text] [Related]
17. Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration.
Kok PW; Kenya PR; Ensering H
Trans R Soc Trop Med Hyg; 1983; 77(2):171-6. PubMed ID: 6868097
[TBL] [Abstract][Full Text] [Related]
18. [Safety and immunogenicity of measles attenuated live vaccine prepared by master seed lot vaccine of Shanghai-191 strain].
Zhang SJ; Xiao QY; Li FJ
Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):423-5. PubMed ID: 20084967
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
[No Abstract] [Full Text] [Related]
20. A comparative study of four live measles vaccines in Israel.
Swartz T; Klingberg W; Nishmi M; Goldblum N; Gerichter C; Yofe Y; Cockburn WC
Bull World Health Organ; 1968; 39(2):285-92. PubMed ID: 5303410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
